Clinical Trials Browser

Phase 2/3 × Neoplasms, Plasma Cell × Thalidomide × Clear all

NCT00038090 2018-10-31

Thalidomide-Dexamethasone for Multiple Myeloma

Phase 2/3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell